Works matching IS 0008543X AND DT 2017 AND VI 123


Results: 710
    1
    2
    3
    4
    5
    6
    7
    9
    10
    11
    12
    13
    14
    15
    16

    Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.

    Published in:
    2017
    By:
    • Spiegel, Marshall L.;
    • Goldman, Jonathan W.;
    • Wolf, Brian R.;
    • Nameth, Danielle J.;
    • Grogan, Tristan R.;
    • Lisberg, Aaron E.;
    • Wong, Deborah J. L.;
    • Ledezma, Blanca A.;
    • Mendenhall, Melody A.;
    • Genshaft, Scott J.;
    • Gutierrez, Antonio J.;
    • Abtin, Fereidoun;
    • Wallace, W.Dean;
    • Adame, Carlos R.;
    • McKenzie, Jordan R.;
    • Abarca, Phillip A.;
    • Li, Alice J.;
    • Strunck, Jennifer L.;
    • Famenini, Sina;
    • Carroll, James M.
    Publication type:
    journal article
    17
    18
    19
    20

    Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.

    Published in:
    2017
    By:
    • Abaza, Yasmin M.;
    • Kadia, Tapan M.;
    • Jabbour, Elias J.;
    • Konopleva, Marina Y.;
    • Borthakur, Gautam;
    • Ferrajoli, Alessandra;
    • Estrov, Zeev;
    • Wierda, William G.;
    • Alfonso, Ana;
    • Chong, Toh Han;
    • Chuah, Charles;
    • Koh, Liang‐Piu;
    • Goh, Boon‐Cher;
    • Chang, Julie E.;
    • Durkes, Daniel E.;
    • Foudray, Maria Cielo;
    • Kantarjian, Hagop M.;
    • Dong, Xiao Qin;
    • Garcia‐Manero, Guillermo;
    • Koh, Liang-Piu
    Publication type:
    journal article
    21
    22
    24
    25
    26
    27
    28

    Issue Information - TOC.

    Published in:
    Cancer (0008543X), 2017, v. 123, n. 24, p. 4739, doi. 10.1002/cncr.30311
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Issue Information.

    Published in:
    Cancer (0008543X), 2017, v. 123, p. 4953, doi. 10.1002/cncr.31129
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48

    Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

    Published in:
    2017
    By:
    • Bhatia, Aarti K.;
    • Lee, Ju‐Whei;
    • Pinto, Harlan A.;
    • Jacobs, Charlotte D.;
    • Limburg, Paul J.;
    • Rubin, Philip;
    • Arusell, Robert M.;
    • Dunphy, Eamonn P.;
    • Khandekar, Janardan D.;
    • Reiner, Seth A.;
    • Baez‐Diaz, Luis;
    • Celano, Paul;
    • Li, Shuli;
    • Li, Yi;
    • Burtness, Barbara A.;
    • Adams, George L.;
    • Pandya, Kishan J.;
    • Lee, Ju-Whei;
    • Baez-Diaz, Luis
    Publication type:
    journal article
    49
    50